Package Insert: Information for the User
Axura 20 mg Film-Coated Tablets
Memantine Hydrochloride
Read this package insert carefully before starting to take the medication as it contains important information for you.
How Axura works
Axura contains the active ingredient memantine hydrochloride.
Axura belongs to a group of medications known as dementia medications.
Memory loss in Alzheimer's disease is due to an alteration in brain signals. The brain contains called N-methyl-D-aspartate (NMDA) receptors that participate in the transmission of important nerve signals in learning and memory. Axura belongs to the group of medications called NMDA receptor antagonists. Axura acts on these receptors by improving the transmission of nerve signals and memory.
What Axura is used for
Axura is used in the treatment of patients with moderate to severe Alzheimer's disease.
Do not take Axura
Warnings and precautionsConsult your doctor or pharmacist before starting to take Axura
In the above situations, treatment should be closely monitored and your doctor should regularly reevaluate the clinical benefit of Axura.
If you have renal insufficiency (kidney problem), your doctor should closely monitor renal function and, if necessary, adjust the memantine dose.
Memantine should be avoided when used with other medicines such as amantadine (for Parkinson's treatment), ketamine (a drug generally used for anesthesia), dextromethorphan (a cough medicine) and other NMDA antagonists.
Children and adolescents
Axura is not recommended for use in children and adolescents under 18 years.
Taking Axura with other medicines
Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medicine.
Specifically, the administration of Axura may alter the effects of the following medicines, so your doctor may need to adjust the dose:
If you are admitted to a hospital, inform your doctor that you are taking Axura.
Taking Axura with food and drinks
You should inform your doctor if you have recently changed or intend to change your diet significantly (for example from a normal diet to a strict vegetarian diet) or if you have renal tubular acidosis (ATR, excess acid-producing substances in the blood due to renal dysfunction [kidney problem]) or severe urinary tract infections, as your doctor may need to adjust the medication dose.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Memantine is not recommended for use in pregnant women.
Breastfeeding
Women taking Axura should discontinue breastfeeding.
Driving and operating machinery
Your doctor will inform you if your condition allows you to drive and use machinery safely. Additionally, Axura may alter your reaction time, making driving or operating machinery inappropriate.
Axura contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is effectively “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, ask your doctor or pharmacist.
Dosage
The recommended dose of Axura in adult patients and elderly patients is 20 mg administered once a day.
To reduce the risk of adverse effects, this dose should be achieved gradually following a daily treatment schedule. To adjust the dose, there are tablets with different doses available.
At the beginning of treatment, you will start taking Axura 5 mg tablets once a day. This dose will be increased weekly by 5 mg until the recommended maintenance dose is reached. The recommended maintenance dose is 20 mg once a day, which is reached at the beginning of the fourth week.
Dosage for patients with renal insufficiency
If you have kidney problems, your doctor will decide on the appropriate dose for your condition. In this case, your doctor should monitor your renal function periodically.
Administration
Axura should be taken orally once a day. To get the most out of your medication, you should take it every day at the same time. The tablets should be swallowed with a little water. The tablets can be taken with or without food.
Treatment duration
Continue taking Axura as long as it is beneficial for you. Your doctor should evaluate the effects of your treatment periodically.
If you take more Axura than you should
If you forget to take Axura
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
Generally, adverse effects are classified as mild to moderate.
Frequent (may affect up to 1 in 10 people):
Infrequent (may affect up to 1 in 100 people):
Very rare (may affect up to 1 in 10,000 people):
Unknown frequency (frequency cannot be estimated from available data):
Alzheimer's disease has been associated with depression, suicidal ideation, and suicide. These events have been reported in patients treated with Axura.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the national notification system included in theAnexo V. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep out of sight and reach of children.
Do not use Axura after the expiration date that appears on the carton and blister pack after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or trash. Dispose of packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. By doing so, you will help protect the environment.
The active ingredient is memantine hydrochloride.
Each pump of the dosifier releases 0.5 ml of solution containing 5 mg of memantine hydrochloride, equivalent to 4.16 mg of memantine.
The other components are potassium sorbate, sorbitol E 420, and purified water.
Appearance of the product and contents of the package
Axura, oral solution, is a transparent, colorless to slightly yellowish solution.
Axura, oral solution, is available in 50 ml, 100 ml, or a multiple pack with 500 ml (10 x 50 ml).
Only some package sizes may be marketed.
Marketing Authorization Holder
Merz Pharmaceuticals GmbH E
ckenheimer Landstr. 100
D-60318 Frankfurt/Main
Germany
Responsible for manufacturing
Merz Pharma GmbH + Co. KGaA
Eckenheimer Landstr. 100
D-60318 Frankfurt/Main
Germany
For more information about this medication, please contact the local representative of the marketing authorization holder.
België/Belgique/Belgien Merz Pharmaceuticals GmbH Tél/Tel: +49 (0)69 1503 – 0 | Lietuva Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
???????? Merz Pharmaceuticals GmbH Te?.: +49 (0)69 1503 – 0 | Luxembourg/Luxemburg HANFF Global Health Solutions s.à r.l. Tél/Tel:+352 4507 07-1 |
Ceská republika Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Magyarország Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Danmark Merz Pharmaceuticals GmbH Tlf: +49 (0)69 1503 – 0 | Malta Clinipharm Co. Ltd Tel: +356 21 43 74 15 |
Deutschland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Nederland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Eesti Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Norge Merz Pharmaceuticals GmbH Tlf: +49 (0)69 1503 – 0 |
Ελλ?δα Merz Pharmaceuticals GmbH Τηλ: +49 (0)69 1503 - 0 | Österreich Merz Pharma Austria GmbH Tel.: +43 1 865 88 95 |
España Merz Therapeutics Iberia, S.L.U. Tel. +34 91 117 89 17 | Polska Centrala Farmaceutyczna CEFARM SA Tel: +48 22 634 02 22 |
France Merz Pharmaceuticals GmbH Tél: +49 (0)69 1503 – 0 | Portugal Merz Therapeutics Iberia, S.L.U. Tel. +34 91 117 89 17 |
Hrvatska Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | România Merz Pharmaceuticals GmbH Tel.: +49 (0)69 1503 – 0 |
Ireland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Slovenija Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 |
Ísland Merz Pharmaceuticals GmbH Sími.: +49 (0)69 1503 – 0 | Slovenská republika Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Italia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Suomi/Finland Merz Pharmaceuticals GmbH Puh/Tel: +49 (0)69 1503 – 0 |
Κ?προς Merz Pharmaceuticals GmbH Τηλ:+49 (0)69 1503 - 0 | Sverige Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Latvija Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | United Kingdom (Northern Ireland) Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Last review date of this leaflet: (MM/AAAA).
For detailed information about this medication, please visit the website of the European Medicines Agency:http://www.ema.europa.eu.
Instructions for the correct use of the dosifier
The solution must not be poured or dispensed directly into the mouth from the bottle or dosifier. Measure the dose in a spoon or in a glass of water using the dosifier.
Removing the cap from the bottle:
The cap must be turned in the opposite direction to the clock, unscrewed completely, and removed (fig. 1).
Mounting the dosifier on the bottle:
Remove the dosifier from the plastic bag (fig. 2) and place it on top of the bottle. Carefully insert the plastic tube into the bottle. Hold the dosifier on the bottle neck and turn it clockwise until it is securely attached (fig. 3). The dosifier should only be screwed on once at the start of use and should never be unscrewed.
How the dosifier works:
The dosifier head should not be pressed down while it is in the closed position. The solution can only be dispensed in the open position. To open, turn the dosifier head in the direction indicated by the arrow until it cannot be turned any further (about one-eighth of a turn, fig. 4). The dosifier is then ready for use.
Preparing the dosifier.
When used for the first time, the dosifier does not dispense the correct amount of oral solution. Therefore, it must be prepared (primed) by pressing the dosifier head down completely five times in a row (fig. 5).
The solution dispensed in this way should be discarded. The next time the dosifier head is pressed down completely (equivalent to one press), it will already dispense the correct dose (fig. 6)
Correct use of the dosifier.
Place the bottle on a flat, horizontal surface, for example on a table, and it should only be used in an upright position. Place a glass with a little water or a spoon under the nozzle. Press the dosifier head down firmly but calmly and sustainably-not too slowly (fig. 7, fig. 8).
The head can then be released and is ready for the next press.
The dosifier should only be used with Axura solution in the bottle provided, not for other products or containers. If the dosifier does not work correctly, consult your doctor or pharmacist. Close the dosifier after use.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.